SESSION TITLE: Respiratory Support Posters
SESSION TYPE: Poster Presentations
PRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PM
PURPOSE: Pediatric medical technology lags behind adult technology by about ten years. To close this gap, inventors in the pediatric space need a comprehensive resource to assist in technology development specifically for children. Multiple academic departments from the University of Minnesota have collaborated with members of local medical device industry to organize and enhance device development resources into one Pediatric Device Innovation Consortium (PDIC) to assist inventors in creating pediatric medical technology. The primary purpose of this consortium is to improve pediatric care through increased access to pediatric specific technology, particularly in high impact areas such as cardiac and pulmonary devices and diagnostics, and intensive care diagnostics and monitoring.
METHODS: PDIC infrastructure was created to provide comprehensive assistance to inventors of high impact pediatric devices at every stage of development. Each project is assessed based off of key criteria for success including pediatric need, pediatric impact, and project feasibility. Each inventor working with the PDIC will have access to 1) leadership in the form of Directors and an Advisory Board with comprehensive engineering, medical, marketing, business, law, financing and regulatory expertise, 2) a diverse inventory of laboratory and medical facilities, 3) a full menu of expert consultants both inside and outside the University of Minnesota for each stage of development, and 4) an expansive network of pediatric clinicians and medical device industry experts.
RESULTS: Initial development has resulted in several pediatric specific projects receiving assistance on single stages of development, including a cardiac valve project and improved tracheostomy device for children.
CONCLUSIONS: The Pediatric Device Innovation Consortium is an innovative way to increase pediatric medical device development, particularly in high impact, high cost projects that would otherwise be ineligible for traditional medical device venture capital funding.
CLINICAL IMPLICATIONS: The clinical impact of Pediatric Medical Device Consortium across the United States will be seen in 5-10 years as pediatric medical devices come to market and are available for pediatric patient use. Immediate impact will occur in the medical device community as pediatric medical devices will become more feasible with Consortium assistance.
DISCLOSURE: The following authors have nothing to disclose: Gwenyth Fischer
No Product/Research Disclosure Information